Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Hiv-Associated Chronic Inflammation.

Macatangay BJC, Jackson EK, Abebe KZ, Comer D, Cyktor J, Klamar-Blain C, Borowski L, Gillespie DG, Mellors JW, Rinaldo CR, Riddler SA.

J Infect Dis. 2019 Jul 6. pii: jiz344. doi: 10.1093/infdis/jiz344. [Epub ahead of print]

PMID:
31282542
2.

Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIV.

Dorazio D, Kitch DW, Utay NS, Macatangay BJ, Landay A, Brown T, Bosch RJ, Pelger AL, Baum JE, Asaad R, Rodriguez B, Lederman MM.

J Virus Erad. 2019 Jan 1;5(1):28-32.

3.

Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.

Garcia-Bates TM, Palma ML, Shen C, Gambotto A, Macatangay BJC, Ferris RL, Rinaldo CR, Mailliard RB.

J Virol. 2019 Feb 19;93(5). pii: e02035-18. doi: 10.1128/JVI.02035-18. Print 2019 Mar 1.

PMID:
30541848
4.

Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Halec G, Waterboer T, Brenner N, Butt J, Hardy WD, DʼSouza G, Wolinsky S, Macatangay BJ, Pawlita M, Detels R, Martínez-Maza O, Hussain SK.

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):e53-e63. doi: 10.1097/QAI.0000000000001916.

PMID:
30531297
5.

Regulatory T cells: the ultimate HIV reservoir?

Rocco J, Mellors JW, Macatangay BJ.

J Virus Erad. 2018 Oct 1;4(4):209-214.

6.

Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?

Wang R, Haberlen SA, Palella FJ Jr, Mugavero MJ, Margolick JB, Macatangay BJC, Martínez-Maza O, Jacobson LP, Abraham AG.

AIDS. 2018 Nov 13;32(17):2547-2556. doi: 10.1097/QAD.0000000000001986.

PMID:
30379686
7.

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART.

Riddler SA, Zheng L, Durand CM, Ritz J, Koup RA, Ledgerwood J, Bailer RT, Koletar SL, Eron JJ, Keefer MC, Macatangay BJC, Cyktor JC, Mellors JW; AIDS Clinical Trials Group A5342 Protocol Team .

Open Forum Infect Dis. 2018 Oct 20;5(10):ofy242. doi: 10.1093/ofid/ofy242. eCollection 2018 Oct.

8.

Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.

Benson CA, Andersen JW, Macatangay BJC, Mailliard RB, Rinaldo CR Jr, Read S, Bozzolo DR, Purdue L, Jennings C, Keefer MC, Glesby M, Tebas P, Russell AF, Martin J, Annunziato P, Popmihajlov Z, Lennox JL.

Clin Infect Dis. 2018 Nov 13;67(11):1712-1719. doi: 10.1093/cid/ciy242.

PMID:
29590326
9.

Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.

Gandhi M, Gandhi RT, Stefanescu A, Bosch RJ, Cyktor JC, Horng H, Louie A, Phung N, Eron JJ, Hogg E, Macatangay BJC, Hensel C, Fletcher CV, Mellors JW, McMahon DK; A5321 Team.

J Infect Dis. 2018 Jun 20;218(2):234-238. doi: 10.1093/infdis/jiy011.

10.

Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy.

Agudelo-Hernandez A, Chen Y, Bullotta A, Buchanan WG, Klamar-Blain CR, Borowski L, Riddler SA, Rinaldo CR, Macatangay BJC.

AIDS. 2017 Sep 24;31(15):2085-2094. doi: 10.1097/QAD.0000000000001602.

11.

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

Gandhi RT, McMahon DK, Bosch RJ, Lalama CM, Cyktor JC, Macatangay BJ, Rinaldo CR, Riddler SA, Hogg E, Godfrey C, Collier AC, Eron JJ, Mellors JW; ACTG A5321 Team.

PLoS Pathog. 2017 Apr 20;13(4):e1006285. doi: 10.1371/journal.ppat.1006285. eCollection 2017 Apr.

12.

Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.

Macatangay BJ, Yang M, Sun X, Morton J, De Gruttola V, Little S, Hogan C, Rinaldo CR; A5217 Team.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):137-141. doi: 10.1097/QAI.0000000000001320.

13.

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.

Castillo-Mancilla JR, Brown TT, Erlandson KM, Palella FJ Jr, Gardner EM, Macatangay BJ, Breen EC, Jacobson LP, Anderson PL, Wada NI.

Clin Infect Dis. 2016 Dec 15;63(12):1661-1667. Epub 2016 Sep 22.

14.

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells.

Macatangay BJ, Riddler SA, Wheeler ND, Spindler J, Lawani M, Hong F, Buffo MJ, Whiteside TL, Kearney MF, Mellors JW, Rinaldo CR.

J Infect Dis. 2016 May 1;213(9):1400-9. doi: 10.1093/infdis/jiv582. Epub 2015 Dec 8.

15.

Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.

He T, Brocca-Cofano E, Gillespie DG, Xu C, Stock JL, Ma D, Policicchio BB, Raehtz KD, Rinaldo CR, Apetrei C, Jackson EK, Macatangay BJ, Pandrea I.

J Virol. 2015 Sep;89(18):9616-30. doi: 10.1128/JVI.01196-15. Epub 2015 Jul 15.

16.

Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?

Macatangay BJ, Rinaldo CR.

Curr Opin HIV AIDS. 2015 Jan;10(1):55-60. doi: 10.1097/COH.0000000000000124. Review.

17.

Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).

Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP.

AIDS Behav. 2015 Apr;19(4):601-11. doi: 10.1007/s10461-014-0927-4.

18.

Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.

Tenorio AR, Chan ES, Bosch RJ, Macatangay BJ, Read SW, Yesmin S, Taiwo B, Margolis DM, Jacobson JM, Landay AL, Wilson CC; A5286 Team.

J Infect Dis. 2015 Mar 1;211(5):780-90. doi: 10.1093/infdis/jiu515. Epub 2014 Sep 11.

19.

Fear of birth defects is a major barrier to soil-transmitted helminth treatment (STH) for pregnant women in the Philippines.

Insetta ER, Soriano AJ, Totañes FI, Macatangay BJ, Belizario VY Jr.

PLoS One. 2014 Feb 26;9(2):e85992. doi: 10.1371/journal.pone.0085992. eCollection 2014.

20.

Knowledge, attitudes and practices among parents and teachers about soil-transmitted helminthiasis control programs for school children in Guimaras, Philippines.

Parikh DS, Totañes FI, Tuliao AH, Ciro RN, Macatangay BJ, Belizario VY.

Southeast Asian J Trop Med Public Health. 2013 Sep;44(5):744-52.

PMID:
24437309
21.

CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.

Schuler PJ, Macatangay BJ, Saze Z, Jackson EK, Riddler SA, Buchanan WG, Hilldorfer BB, Mellors JW, Whiteside TL, Rinaldo CR.

AIDS. 2013 Jun 19;27(10):1545-55. doi: 10.1097/QAD.0b013e328360c7f3.

22.

Assessment of a school-based mass treatment for soil-transmitted helminth infections in Capiz, the Philippines.

Bacon KM, Shah M, Taylor L, Macatangay BJ, Veldkamp P, Belizario VY Jr.

Southeast Asian J Trop Med Public Health. 2012 May;43(3):589-600.

PMID:
23077838
23.

MDSC: a new player in HIV immunopathogenesis.

Macatangay BJ, Landay AL, Rinaldo CR.

AIDS. 2012 Jul 31;26(12):1567-9. doi: 10.1097/QAD.0b013e328355e682. No abstract available.

24.

Regulatory T cells in HIV immunotherapy.

Macatangay BJ, Rinaldo CR.

HIV Ther. 2010 Nov;4(6):639-647.

25.

Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.

Macatangay BJ, Zheng L, Rinaldo CR, Landay AL, Pollard RB, Pahwa S, Lederman MM, Bucy RP.

Clin Vaccine Immunol. 2010 Sep;17(9):1452-9. doi: 10.1128/CVI.00498-09. Epub 2010 Jul 14.

26.

PD-1 blockade: A promising immunotherapy for HIV?

Macatangay BJ, Rinaldo CR.

Cellscience. 2009 Apr 27;5(4):61-65.

27.

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.

Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, Rinaldo CR.

PLoS One. 2010 Mar 24;5(3):e9852. doi: 10.1371/journal.pone.0009852.

28.

A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.

Belizario VY, Amarillo ME, de Leon WU, de los Reyes AE, Bugayong MG, Macatangay BJ.

Bull World Health Organ. 2003;81(1):35-42. Epub 2003 Mar 11.

Supplemental Content

Loading ...
Support Center